59 results
Page 2 of 3
DEFM14A
xs917k
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
fo9lyb qb
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
xlqsfhygcm
6 Mar 20
Preliminary proxy related to merger
5:32pm
8-K
EX-2.1
gmantmqt7 djyrcythqn
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-2.1
mouz74eo
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.1
cndd80b7t w64z1
11 Mar 19
Results of Operations and Financial Condition
4:12pm
8-K
EX-1.1
guhenf ev
9 Nov 18
Entry into a Material Definitive Agreement
5:10pm
424B5
36rtpohw
9 Nov 18
Prospectus supplement for primary offering
4:49pm
8-K
EX-1.1
vz7 p0dllhm3
28 Jun 18
Zafgen Announces Proposed Offering of Common Stock
5:01pm
424B5
ok1pag
28 Jun 18
Prospectus supplement for primary offering
4:54pm
424B5
wxgv e01ff
27 Jun 18
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
s6wnz2qd
7 Jun 18
Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
5:06pm